Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors.
about
Could there be light at the end of the tunnel? Mesocaval shunting for refractory esophageal varices in patients with contraindications to transjugular intrahepatic portosystemic shuntEvaluation and Management of Hepatic Encephalopathy: Current Status and Future DirectionsTransjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascitesThe brain following transjugular intrahepatic portosystemic shunt: the perspective from neuroimaging.Functional hepatic flow in patients with liver cirrhosis.The Evolution of Transjugular Intrahepatic Portosystemic Shunt: Tips.Evaluation and management of patients with refractory ascites.Emerging drugs for hepatic encephalopathy.Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review.Transjugular intrahepatic portosystemic shunt in the management of refractory ascitesHepatic encephalopathy therapy: An overview.TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial.Transjugular intrahepatic portosystemic shunt treatment of variceal bleeding in an unselected patient population.Randomised clinical trial: L-ornithine-L-aspartate reduces significantly the increase of venous ammonia concentration after TIPSS.No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.Race and Gradient Difference Are Associated with Increased Risk of Hepatic Encephalopathy Hospital Admission After Transjugular Intrahepatic Portosystemic Shunt PlacementEfficacy and Safety of Indwelling Pleural Catheters in Management of Hepatic Hydrothorax: A Systematic Review of LiteratureTreatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS)
P2860
Q26739786-E787B9DA-3F6B-47C8-9183-C46108A00BD0Q26744689-3EF8157C-06B0-454C-828F-2C8E36A7C8DCQ35720298-B386749A-AFA2-4C17-A130-B2D1118E4E2DQ35787166-2CEA8CAA-8E87-4EC0-BE0E-26F2960C0A0BQ36502584-F1F15283-118B-40B8-9DA7-0BCBAD165C17Q36961977-9C16B8DF-DB6F-4DDF-9ECF-1972DE925A34Q37122130-212B59EB-79B1-426A-A1CE-821939CFB840Q37529838-30E551C0-ACFD-4641-8CC4-4D4653AD12ECQ37830756-A9C00AD3-69A4-463D-96D8-5B27F6827287Q42593002-59210847-12EF-4738-8FA1-E87B649342CDQ42730495-4DED2194-E673-4D1E-9A64-ABFA66CB373FQ43875848-68DEF18D-ECD2-49B9-BED8-E86D72943408Q49484410-081CF501-25A9-4937-808D-09420A90529BQ50643497-7C2AF09A-7700-4C85-ADCA-8DD4F8EB1BD1Q52150971-4E3DED24-9344-4FBB-A57E-F018B61A41F3Q57300679-4A508252-892C-4248-B484-1435196BBD09Q58566094-A29AF422-23FE-4ED2-A24E-A6D50B8D5762Q58579662-F1792F26-5258-43BD-BCBD-7B52070C4808
P2860
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Hepatic encephalopathy after t ...... t. Incidence and risk factors.
@en
Hepatic encephalopathy after t ...... t. Incidence and risk factors.
@nl
type
label
Hepatic encephalopathy after t ...... t. Incidence and risk factors.
@en
Hepatic encephalopathy after t ...... t. Incidence and risk factors.
@nl
prefLabel
Hepatic encephalopathy after t ...... t. Incidence and risk factors.
@en
Hepatic encephalopathy after t ...... t. Incidence and risk factors.
@nl
P2093
P356
P1476
Hepatic encephalopathy after t ...... t. Incidence and risk factors.
@en
P2093
F Fiaccadori
F Salvatori
G Pedretti
L Capocaccia
R Lionetti
P2860
P2888
P304
P356
10.1007/BF02282344
P577
1996-03-01T00:00:00Z